A director at Floridienne S.A. sold 2,000 shares at 510.000EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
We increased our FY24 numbers substantially as Floridienne recorded strong growth in 9M24 y/y as 9M24 sales came in at € 502.4m (+25% y/y), and 9M24 EBITDA was €84.9m (+€35.9m y/y) and a 9M24 net result came in at € 17.1m (+€8.0m y/y). Floridienne indicated that this was mainly thanks to the dynamism of its historical activities and the successful integration of Biotrop. The Foot Division is succeeding in increasing its profitability. BioFirst is growing significantly on its historical market of...
Without giving exact numbers, Floridienne indicated they recorded in 1Q24 an increase in sales and EBITDA. Important for the future is that Biotrop, the leading Brazilian company in the field of biological solutions for agriculture and one of the biggest in the world, is currently being integrated in BioFirst (ex Biobest). Our TP of € 835 is the average of our updated DCF (€ 850 per share) and SOTP (€ 819 per share). We maintain our Accumulate rating.
Floridienne announced that its subsidiary Biobest , a world leader in pollination and integrated pest management (IPM), will acquire Brazilian Biotrop from Aqua Capital and GIC investment funds. This large-scale transaction gives Biobest a significant position in South America and allows it to expand its range of biological solutions, which will now include biocontrol (beneficial insects and biopesticides), inoculants, biostimulants and pollination for both greenhouse crops, Biobest's traditiona...
One year after our 'Hydrogen Primer' we now take a closer look into the energy transition as we are analysing how we are doing on our "Road -or should we say Race- to Net Zero". Global temperatures are at a record high, with the Earth 1.1°C warmer than preindustrial levels. To limit the increase below 1.5°C, emissions must be reduced by 45% by 2030 and reach Net Zero by 2050. Current commitments fall short of these targets. We highlight that achieving Net Zero will require substantial financia...
Adyen: Adding financial products to the offering Avantium: Close of financing package for FDCA plant Floridienne: FY21 : Successful integration of recent acquisitions Hyloris: Financing the repurposing pivot KPN: Proposal to lower fiber wholesale rates by >10-30% Recticel: Closing divestment of Bedding
ABN Amro: Selling AAV Life Insurance stake to NN Group DSM: 4Q adj. EBITDA beat of 5%, FY22 guidance in line Euronav: Welcoming back an old friend Floridienne: The fairy tale of ‘The Bee’ and ‘The Unicorn’ Inventiva: 2021: Increased cash burn due to Native3 trial IO&W: FY21 Results, Positive Guidance Randstad: 4Q21: Again comfortably beating expectations Resilux: Quvadec(Quva) acquires De Cuyper Family’s shares Ter Beke: RawMat issues and issues with important client Xior: Fervet opus
Biotalys: Long-term strategic partnership with Biobest Floridienne: Strategic partnership between Biobest and Biotalys Hyloris: The fourth new asset of the year: Alenura Lotus Bakeries: FF2032 5th investment : “The Good Crisp Company” Proximus: Bringing TeleSign public through SPAC merger
Biocartis: 510(k) for SeptiCyte RAPID Deceuninck: Sponsorship agreement with Alpecin – Fenix cycling Floridienne: A sharp rise in its 9M21 result in all 3 divisions ForFarmers: € 50m SBB announced Proximus: Considering strategic options involving TeleSign
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.